Skip to search formSkip to main contentSkip to account menu

Debio 1347

Known as: Debiopharm 1347, FGFR Inhibitor Debio 1347, debio 1347-101 
An orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Antiretroviral therapy (ART) suppresses HIV replication, but does not cure the infection because replication-competent virus… 
2019
2019
Background Cholangiocarcinoma (CCA), an aggressive epithelial neoplasm of biliary tract, presents limited treatment options and… 
2018
2018
447Background: BTC are aggressive tumors with limited treatment options and poor overall survival. Aberrant FGFR signaling has… 
2017
2017
2500Background: Oncogenic alterations in fibroblast growth factor receptors (FGFR) are seen across multiple solid tumor… 
2015
2015
2540 Background: Deregulated fibroblast growth factor receptor (FGFR) signaling is associated with tumorigenesis. Debio 1347 is… 
2011
2011
Resumen es: Introduccion La seguridad y la eficacia del tratamiento endovascular de la aorta toracica descendente dependen de… 
2009
2009
Sao analisados resultados de capturas de seis especies do genero Cyclocephala (Coleoptera, Scarabaeidae) fototacticos feitas com… 
Review
1994
Review
1994
The northern right whale dolphin (Lissodelphis borealis) has experienced very high levels of fishery-induced mortality in…